Stock BSTC BIOSPECIFICS TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights BioSpecifics Technologies Corp.

Equities

BSTC

US0909311062

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Endo International plc completed the acquisition of BioSpecifics Technologies Corp. from Edwin H. Wegman Marital Trust, Renaissance Technologies Corp., BlackRock, Inc..
CI
Biospecifics Technologies Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
Endo International plc entered into an agreement and plan of merger to acquire BioSpecifics Technologies Corp. from Edwin H. Wegman Marital Trust, Renaissance Technologies Corp., BlackRock, Inc. and others for approximately $650 million.
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on May 23, 2019.
CI
Biospecifics Technologies Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
BioSpecifics Technologies Corp. Provides Revenue Guidance for the Second Half of 2020
CI
BioSpecifics Technologies Corp.'s Equity Buyback announced on May 23, 2019, has expired with 18,960 shares, representing 0.26% for $1.03 million.
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on May 23, 2019.
CI
Biospecifics Technologies Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Biospecifics Technologies Corp. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on May 23, 2019.
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on May 23, 2019.
CI
Biospecifics Technologies Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on May 23, 2019.
CI
Biospecifics Technologies Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
BioSpecifics Technologies Corp. announces an Equity Buyback for $4 million worth of its shares.
CI
BioSpecifics Technologies Corp. authorizes a Buyback Plan.
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on December 12, 2013.
CI
Biospecifics Technologies Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019
CI
Tranche Update on BioSpecifics Technologies Corp.'s Equity Buyback Plan announced on December 12, 2013.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BSTC Stock
  4. News BioSpecifics Technologies Corp.
  5. Highlights